Volume 8, Number 3—March 2002
Synopsis
Human Campylobacteriosis in Developing Countries1
Akitoye O. Coker*
, Raphael D. Isokpehi*, Bolaji N. Thomas*, Kehinde O. Amisu*, and C. Larry Obi†
, Raphael D. Isokpehi*, Bolaji N. Thomas*, Kehinde O. Amisu*, and C. Larry Obi†Table 4
Trends in Resistance to Ciprofloxacin by Campylobacter jejuni in selected developed countries up to year 2000
| Country | Period | Resistance strains (%) | Ref. | |
|---|---|---|---|---|
| Initial | Year 2000 | |||
| Freiburg, Germany | 1992-2000 | 22 | 32 | 41 |
| Styria, Austria | 1996-2000 | 25.2 | 40.2 | 42 |
| England and Wales, UK | 1993-2000 | 10 | 14.8 | 44 |
| Philadelphia, USA | 1995-2000 | <10 | 36 | 45 |
| Oslo, Norway | 1988-2000 | 6.1 | 36 | 46 |
1 Portions of this review were presented at the World Health Organization Consultation on the Increasing Incidence of Campylobacteriosis in Humans, Copenhagen, Denmark, November 1-25, 2000. In addition, relevant emerging information from the 11th International Workshop on Campylobacter, Helicobacter and Related Organisms, held in Freiburg, Germany, September 1-5, 2001, are included.
